For example, heterozygous EZH2 mutations within the catalytic SET domain have been identified in approximately 20% of cases of germinal centre B‐cell (GCB)‐like diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL) [9]. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.